Latest Biotech News

Pharma industry groups escalated legal pressure against U.S. drug pricing proposals, arguing the latest Medicare “most-favored nation” (MFN) pilot oversteps statutory authority. Separately, the EU...

Caribou Biosciences said it is exploring strategic alternatives and will discontinue further development of its donor-derived CAR-T programs after failing to secure financing for planned...

Lycia Therapeutics filed for an IPO to raise $100 million, aiming to push clinical development of therapies targeting peanut and tree nut allergies. Its lead candidate, LCA-0061, uses an...

Cerevance reported Phase 3 results for solengepras showing a reduction in Parkinson’s patients’ daily “off” time alongside other symptoms, setting up a potential regulatory discussion on approval....

A new study in Science Translational Medicine reports that the antimicrobial protein calprotectin is induced in neonatal intestinal epithelial cells in response to commensal bacteria. In mouse...

A pooled analysis across four clinical trials found that liver metastases are a strong negative prognostic factor for pancreatic cancer patients treated with chemotherapy, but they did not...

Meta and Google expanded collaboration funding to create virtual cell models, aiming to predict cellular behavior with AI-driven biology and simulation workflows. The project is positioned to move...

Researchers identified hidden gene deletions that explain severe Friedreich ataxia cases previously misdiagnosed by standard testing, distinguishing covert FXN copy loss from repeat expansion...

A new preoperative nomogram approach aims to reduce unnecessary lymph node surgery in hormone receptor-positive, HER2-negative breast cancer by predicting hidden node spread using routine clinical...

A review argues electrical signals can improve bioprocess control by detecting early signs of culture failure faster than conventional assays in biologics manufacturing. It highlights advances in...

Genentech expanded its Parkinson’s disease ambitions by striking a large licensing deal with Alector for AL050, an engineered enzyme replacement therapy tied to GBA1-linked glucocerebrosidase...

AbbVie and Genmab secured a first-line diffuse large B-cell lymphoma headline with Epkinly, reporting a Phase 3 win in newly diagnosed patients when added to R-CHOP. The companies said the therapy...

Caribou Biosciences moved to exit cell therapy after failing to secure funding for late-stage progress of its allogeneic CAR-T programs. The company said its board approved exploring strategic...

Lycia Therapeutics filed for an initial public offering in a bid to fund clinical development for disease-modifying therapies targeting peanut and tree nut allergies. The California-based biotech...

The Trump administration said it would start developing a system requiring health insurers to disclose prescription drug prices, with a hoped-for final plan by next May. The proposal revives...

Multiply Labs raised $75 million to scale robotic drug manufacturing for cell therapies. The company builds robotics systems meant to run steps between existing cell-therapy manufacturing...

Cerevance reported Phase 3 progress for solengepras, an oral therapy for Parkinson’s disease aimed at reducing patients’ daily “off” time. In the trial, the company said solengepras cut off-time...

Shionogi moved to expand its rare disease portfolio by acquiring IntraBio for $2 billion. The deal is designed to add Aqneursa (levacetylleucine), an approved therapy for neurological...

A set of developers and researchers highlighted advances in non-invasive, data-driven cancer diagnostics in a multicenter setting, including AI approaches aimed at reducing unnecessary procedures....

Researchers reported that a serotonin receptor pathway can drive osteosarcoma metastasis and chemotherapy resistance through a feedback network involving c-MYC/MAPK signaling and...